Innate Pharma SA | 2.730 / +6.47% |
Date/Time | 07/01 / 17:35 |
Chg. / Chg.(%) | 0.166 / +6.47% |
Bid | 2.510 / 1160 |
Ask | 2.740 / 30 |
Open | 2.570 |
Previous Close | 2.564 |
High | 2.740 |
Low | 2.520 |
Volume [EUR] | 483,459.710 |
Volume [Units] | 183,917 |
Price fixings | 340 |
ISIN | FR0010331421 |
Security | IPH |
Exchange | Euronext - Paris |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Euronext - P.. | 2.730 | ![]() |
183,917 |
London Inter.. | 2.734 | ![]() |
40,346 |
Cboe Europe .. | 2.74 | ![]() |
5,392 |
Turquoise | 2.73 | ![]() |
2,822 |
TradeGate | 2.74 | ![]() |
2,708 |
Düsseldorf | 2.702 | ![]() |
0 |
München | 2.594 | ![]() |
0 |
Berlin | 2.554 | ![]() |
0 |
Frankfurt | 2.5540 | ![]() |
0 |
Stuttgart | 2.658 | ![]() |
0 |
Lang & Schwa.. | 2.688 | ![]() |
|
gettex | 2.7380 | ![]() |
|
Quotrix | 2.5900 | ![]() |
|
Nasdaq Other.. | 2.6000 | 100 | |
Cboe Europe .. | 4.08 | 145 | |
Cboe Europe .. | 4.08 | 145 |
News
- Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D
02/04/2022 / 07:30 - GlobeNewswire - Noema Pharma expands its Board of Directors with the appointments of Catherine Moukheibir and Ilise Lombardo
11/09/2021 / 14:55 - GlobeNewswire - Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021
09/23/2021 / 07:00 - GlobeNewswire - Monalizumab Data from COAST Trial Presented at ESMO Congress 2021
09/17/2021 / 13:45 - GlobeNewswire - Innate Pharma Reports First Half 2021 Financial Results and Business Update
09/15/2021 / 07:00 - GlobeNewswire